| Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate Cancer (NCT04832113) | Centre Leon Berard | 2021-06-21 |
| A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer (NCT04729114) | Astellas Pharma Global Development, Inc. | 2021-06-14 |
| The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer (NCT04936334) | Clinton Bahler | 2021-06-11 |
| Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases (NCT05106699) | Shanghai Proton and Heavy Ion Center | 2021-06-08 |
| 4-aminopyridine Treatment for Nerve Injury (NCT03701581) | John Elfar | 2021-06-05 |
| Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy (NCT04773821) | Assistance Publique - Hôpitaux de Paris | 2021-06-02 |
| Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy (NCT04718987) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-06-01 |
| Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth) (NCT04486846) | Duke University | 2021-06-01 |
| Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees (NCT05040672) | Libbs Farmacêutica LTDA | 2021-06-01 |
| A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors (NCT04903873) | Eutilex | 2021-05-31 |
| Embr Thermal Device for Hot Flash Management in Prostate Cancer (NCT04892914) | Embr Labs, Inc. | 2021-05-28 |
| Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) (NCT04748042) | University of Michigan Rogel Cancer Center | 2021-05-28 |
| DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) (NCT04869462) | Aesculap AG | 2021-05-27 |
| Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP) (NCT04581109) | University Hospital, Montpellier | 2021-05-27 |
| Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy (NCT04685928) | Chinese University of Hong Kong | 2021-05-27 |
| A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients (NCT04946214) | University of Miami | 2021-05-26 |
| Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling (NCT05132868) | Stanford University | 2021-05-25 |
| Postoperative Prognosis Management Service Based mHealth for Prostate Cancer Patients (NCT05021952) | Seoul St. Mary's Hospital | 2021-05-21 |
| Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT04781374) | Beth Israel Deaconess Medical Center | 2021-05-21 |
| Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ). (NCT04745871) | University Hospital, Brest | 2021-05-20 |
| ProsTIC Registry of Men Treated With PSMA Theranostics (NCT04769817) | Peter MacCallum Cancer Centre, Australia | 2021-05-19 |
| Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients (NCT04832958) | IRCCS San Raffaele | 2021-05-15 |
| Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment (NCT04890314) | Weill Medical College of Cornell University | 2021-05-15 |
| Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients (NCT01972867) | Angiodynamics, Inc. | 2021-05-13 |
| Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors (NCT04827459) | University of Michigan Rogel Cancer Center | 2021-05-12 |
| Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC (NCT04821622) | Pfizer | 2021-05-12 |
| Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia (NCT04803305) | Pfizer | 2021-05-11 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIA (NCT04863352) | Sykehuset Innlandet HF | 2021-05-04 |
| PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness (NCT04995198) | Prostate Cancer Clinical Trials Consortium | 2021-05-03 |
| Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis (NCT05584787) | San Carlo di Nancy Hospital | 2021-05-01 |
| Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate (NCT04736108) | West China Hospital | 2021-05-01 |
| Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy (NCT04891536) | Ignacio Puche Sanz | 2021-05-01 |
| 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer (NCT04727736) | Ashok Muthukrishnan | 2021-05-01 |
| A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening (NCT05180305) | TSH Biopharm Corporation Limited | 2021-04-27 |
| CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours (NCT05518799) | The Netherlands Cancer Institute | 2021-04-22 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies (NCT04873427) | Clinica Luganese Moncucco | 2021-04-15 |
| ABlative Radiotherapy (for) Unfavorable Prostate Tumors (NCT04831983) | University of Milano Bicocca | 2021-04-15 |
| Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System (NCT04732156) | Hospices Civils de Lyon | 2021-04-14 |
| Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT (NCT04846894) | Jin-Sook Ryu | 2021-04-13 |
| A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy (NCT05547061) | Cellbion Co., Ltd. | 2021-04-12 |
| Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique (NCT05231915) | University Hospital Center of Martinique | 2021-04-09 |
| A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety (NCT04681144) | Bayer | 2021-04-08 |
| Salvage HDR for Locally Recurrent Prostate Cancer (NCT04231006) | Aarhus University Hospital | 2021-04-01 |
| Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary Incontinence (NCT04804839) | Hacettepe University | 2021-04-01 |
| Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations (NCT07416812) | Institute of Oncology Ljubljana | 2021-03-29 |
| A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study) (NCT05035732) | M.D. Anderson Cancer Center | 2021-03-25 |
| Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer (NCT04845503) | University Hospital Heidelberg | 2021-03-25 |
| Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor (NCT04825002) | Asan Medical Center | 2021-03-22 |
| Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer (NCT04702633) | Assistance Publique - Hôpitaux de Paris | 2021-03-19 |
| 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer (NCT04483414) | Dana Mathews | 2021-03-19 |
| Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients (NCT04560452) | AstraZeneca | 2021-03-15 |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT04742959) | TransThera Sciences (Nanjing), Inc. | 2021-03-14 |
| Plasma Exosome RNA to Diagnose Prostate Cancer (NCT06604130) | Xijing Hospital | 2021-03-12 |
| STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study (NCT05455736) | Azienda Ospedaliero-Universitaria Careggi | 2021-03-11 |
| To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers (NCT04783636) | Peptron, Inc. | 2021-03-11 |
| Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy (NCT04638088) | Elsan | 2021-03-08 |
| Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer (NCT04337580) | Wake Forest University Health Sciences | 2021-03-05 |
| TH1902 in Patients With Advanced Solid Tumors (NCT04706962) | Theratechnologies | 2021-03-04 |
| Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer (NCT05818631) | José Joaquín Mira | 2021-03-01 |
| Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention (NCT04555343) | Fraser Health | 2021-03-01 |
| Prostate PMSABR Study (NCT04742972) | Darren Poon | 2021-02-25 |
| Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer (NCT04298983) | University of Alabama at Birmingham | 2021-02-25 |
| An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum (NCT05384002) | Fondazione del Piemonte per l'Oncologia | 2021-02-24 |
| Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients (NCT04575402) | Cedars-Sinai Medical Center | 2021-02-19 |
| Early Detection of Prostate Cancer (NCT04556916) | University Hospital, Montpellier | 2021-02-19 |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells (NCT04628806) | Charite University, Berlin, Germany | 2021-02-17 |
| TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy (NCT04701021) | Ultimovacs ASA | 2021-02-17 |
| The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer (NCT04167969) | Memorial Sloan Kettering Cancer Center | 2021-02-17 |
| Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer (NCT04641078) | University Hospital, Ghent | 2021-02-12 |
| Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer (NCT04582656) | Koelis | 2021-02-11 |
| DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer (NCT04766190) | Lauren Hamel | 2021-02-10 |
| Detection of Cancer in Breath Samples by Trained Detection Dogs (NCT06255041) | SpotitEarly | 2021-02-10 |
| pCHIP: Prostate Cancer Health Impact Program (NCT04293406) | Weill Medical College of Cornell University | 2021-02-10 |
| Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® (NCT05140512) | Luye Pharma Group Ltd. | 2021-02-04 |
| Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy (NCT04053842) | Glenn Bauman | 2021-02-04 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer (NCT05557604) | Regina Elena Cancer Institute | 2021-02-02 |
| 'OLAP' (OLAparib Regulatory Post-marketing Surveillance) (NCT04553926) | AstraZeneca | 2021-02-01 |
| Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project (NCT04879563) | Region Örebro County | 2021-02-01 |
| PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer (NCT04700332) | Hoag Memorial Hospital Presbyterian | 2021-02-01 |
| MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02) (NCT05183074) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-02-01 |
| Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26 (NCT04746638) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2021-02-01 |
| Novel MRI Assessment of Prostate Cancer VALIDATE-PRO (NCT05017181) | University College, London | 2021-01-29 |
| A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents. (NCT05137067) | Optimal Health Research | 2021-01-20 |
| PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE (NCT05022914) | Azienda Ospedaliero-Universitaria Careggi | 2021-01-19 |
| [Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients (NCT04693169) | Peking University Cancer Hospital & Institute | 2021-01-15 |
| Mental Wellbeing and Quality of Life in Prostate Cancer (NCT04647474) | King's College London | 2021-01-15 |
| Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome (NCT04622761) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2021-01-15 |
| To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer Patients (NCT04687709) | Chinese University of Hong Kong | 2021-01-14 |
| Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer (NCT04842890) | The New York Proton Center | 2021-01-08 |
| PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer (NCT04557501) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-01-06 |
| DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy (NCT07265414) | Istituto Clinico Humanitas | 2021-01-01 |
| Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy (NCT04027270) | University of Missouri-Columbia | 2021-01-01 |
| A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3 (NCT06507462) | Anhui Provincial Hospital | 2021-01-01 |
| Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) (NCT04349501) | University of California, San Diego | 2020-12-29 |
| SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer (NCT04861415) | Dr. Gerard Morton | 2020-12-23 |
| A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors (NCT04672460) | Pfizer | 2020-12-21 |
| Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments (NCT04705038) | University of Chicago | 2020-12-18 |